General Information


DRACP ID  DRACP04113

Peptide Name  

Sequence  XXLFXXLLXYLRXF

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C57H73N11O4

Absent amino acids  ACDEGHIKMNPQSTVW

Common amino acids  X

Mass  186833

Pl  9.35

Basic residues  1

Acidic residues  0

Hydrophobic residues  6

Net charge  1

Boman Index  1058

Hydrophobicity  107.14

Aliphatic Index  111.43

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  114.62

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33281761

Title  D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17131

DRACP is developed by Dr.Zheng's team.